Evidence map›Paper›PMID 33167339›Full record

ReviewMolecules (Basel, Switzerland)2020

Antimicrobial Activity of Calixarenes and Related Macrocycles.

Dmitriy N Shurpik, Pavel L Padnya, Ivan I Stoikov, Peter J Cragg

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Cyclophane-Based Dendrimers: Today and Tomorrow.Molecules (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Pyrgos[Science advances · 2024
    Article
  12. Article
  13. Bismacrocycle: Structures and Applications.Molecules (Basel, Switzerland) · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dmitriy N ShurpikA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlyovskaya St, 18, 420008 Kazan, Russia.ORCID 0000-0002-7914-6533
Pavel L PadnyaA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlyovskaya St, 18, 420008 Kazan, Russia.ORCID 0000-0002-1924-8028
Ivan I StoikovA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlyovskaya St, 18, 420008 Kazan, Russia.ORCID 0000-0002-3019-7866
Peter J CraggSchool of Pharmacy and Biomolecular Sciences, University of Brighton, Huxley Building, Moulsecoomb, Brighton, East Sussex BN2 4GJ, UK.ORCID 0000-0002-6134-2093

Funding

Council on grants of the President of the Russian Federation NSh-2499.2020.3
6 · The paper itself

Abstract

Calixarenes and related macrocycles have been shown to have antimicrobial effects since the 1950s. This review highlights the antimicrobial properties of almost 200 calixarenes, resorcinarenes, and pillararenes acting as prodrugs, drug delivery agents, and inhibitors of biofilm formation. A particularly important development in recent years has been the use of macrocycles with substituents terminating in sugars as biofilm inhibitors through their interactions with lectins. Although many examples exist where calixarenes encapsulate, or incorporate, antimicrobial drugs, one of the main factors to emerge is the ability of functionalized macrocycles to engage in multivalent interactions with proteins, and thus inhibit cellular aggregation.

Indexed as

BiofilmsAmino Acid MotifsAnimalsAnti-Infective AgentsCalixarenesDrug Delivery SystemsGlycosylationHumansLectinsMetalsNanoparticlesOxazolesPhenylalanineProdrugsSolubilitySulfonamidesAnti-Infective AgentsCalixarenesLectinsMetalsOxazolesPhenylalanineProdrugsresorcinareneSulfonamidesThiadiazolesThiazolesVancomycinWaterantibioticbiofilm inhibitioncalixarenefungicidepillarareneresorcinarene

Identifiers

PMID33167339
PMCPMC7663816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.